4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-22-016056
Executive Vice President gave up 13,237 shares (to pay taxes)
- Executive Vice President acquired 37,655 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Todisco Joseph Executive Vice President | 2022-03-01 | Option exercise | +11,111 | 311,007 | D | ||
| Todisco Joseph Executive Vice President | 2022-03-01 | Shares withheld for taxes | −3,906 | $4.45 | $17,382 | 307,101 | D |
| Todisco Joseph Executive Vice President | 2022-03-01 | Option exercise | +26,544 | 333,645 | D | ||
| Todisco Joseph Executive Vice President | 2022-03-01 | Shares withheld for taxes | −9,331 | $4.45 | $41,523 | 324,314 | D |
| Derivatives | |||||||
| Todisco Joseph Executive Vice President | 2022-03-01 | Option exercise · Restricted Stock Units | −11,111 | 11,111 | D | ||
| Todisco Joseph Executive Vice President | 2022-03-01 | Option exercise · Restricted Stock Units | −26,544 | 79,634 | D | ||
| Todisco Joseph Executive Vice President | 2022-03-03 | Grant or award · Restricted Stock Units | +144,928 | 144,928 | D | ||
| Todisco Joseph Executive Vice President | 2022-03-03 | Grant or award · Performance-Based Restricted Stock Units | +289,856 | 289,856 | D | ||
Loading xslF345X03/doc4.xml…